Healing of Burns and the Effect of Shockwave Therapy on the Recovery of Skin Grafts
Accelerated Healing of Second Degree Burns and the Effect of Musculoskeletal Shockwave Therapy on the Recovery of Skin Graft Donor Sites
1 other identifier
interventional
100
1 country
1
Brief Summary
The study is to review whether musculoskeletal shockwave therapy (ESWT) can speed up the healing of second-degree burns as well as skin-graft donor sites. In both cases, the primary hypothesis is the shortened period leading up to the complete healing of the wound (reepithelization). The secondary hypothesis in the course of the study assesses: the rare manifestation of undesirable local events (e.g. reddening, swelling, hematoma).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Nov 2006
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 16, 2010
CompletedFirst Posted
Study publicly available on registry
November 17, 2010
CompletedNovember 18, 2010
November 1, 2010
3.9 years
November 16, 2010
November 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The period leading up to the complete healing of the wound (reepithelization).
Secondary Outcomes (1)
Manifestation of undesirable local events (e.g. reddening, swelling, hematoma).
Study Arms (3)
superficial 2nd degree burn
EXPERIMENTALGroup A (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who have sustained a superficial 2nd degree burn on ≥1% and ≤30% of the surface of the body.
deep 2nd degree burn
EXPERIMENTALGroup B (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who have sustained a deep 2nd degree burn on ≥1% and ≤30% of the surface of the body.
skin excision for the purpose of a skin graft
EXPERIMENTALGroup C (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of BBS.
Interventions
ESWT is administered as a one-off treatment on the wound surfaces within 24 hours of a 2nd degree burn trauma and immediately after an intraoperative skin graft excision procedure. A defocused sound head is orthogradely applied to the burn wound or the donor site. 100 impulses/cm² is administered at 20 seconds per cm². The defocused sound head is placed on the wound along with a sterile gel (Lavaseptgel®, Octenidingel®) and a sterile protection foil. The shockwaves deployed are not at an energy density that is painful. This single application of ESWT is followed by routine dressing using Mepitel® in combination with Polyhexanid/Octenidin®.
Eligibility Criteria
You may qualify if:
- Group A (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who have sustained a superficial 2nd degree burn on ≥1% and ≤30% of the surface of the body.
- Group B (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who have sustained a deep 2nd degree burn on ≥1% and ≤30% of the surface of the body.
- Group C (n=50): Consent-capable male and female patients between ≥18 and ≤80 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of BBS.
You may not qualify if:
- pregnancy
- below 18 or above 80 years of age
- burns requiring artificial respiration, since consent for the study participation is unobtainable
- extent of burns ≤1% to ≥30% of the body surface
- diabetes mellitus requiring insulin
- dialysis-dependent
- ongoing chemotherapy treatment
- drug abuse
- systemic skin diseases
- systemic and local cortisone therapy
- Excluded from the study are those with burns in the regions:
- head, face, neck
- proximal ventral and dorsal thorax
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unfallkrankenhaus Berlin
Berlin, State of Berlin, Germany
Related Publications (1)
Ottomann C, Stojadinovic A, Lavin PT, Gannon FH, Heggeness MH, Thiele R, Schaden W, Hartmann B. Prospective randomized phase II Trial of accelerated reepithelialization of superficial second-degree burn wounds using extracorporeal shock wave therapy. Ann Surg. 2012 Jan;255(1):23-9. doi: 10.1097/SLA.0b013e318227b3c0.
PMID: 21775883DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernd Hartmann, MD
Unfallkrankenhaus Berlin
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 16, 2010
First Posted
November 17, 2010
Study Start
November 1, 2006
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
November 18, 2010
Record last verified: 2010-11